Donald J. Santel

Donald J. Santel is a declared insider at 2 companies (board member); the most frequent names are Oyster Point Pharma, Inc. and Surrozen, Inc./DE. Over a trading history stretching from 30 July 2021 to 3 January 2023, the count stands at 4 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 4 January 2023: a transaction, in Oyster Point Pharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.